Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2022-04-04 AGM Information
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting of Medivir AB (publ)
AGM Information Classification · 100% confidence The document is explicitly titled "Notice of Annual General Meeting of Medivir AB (publ)". It details the date, time, location, procedures for participation (in person or advance voting), shareholder rights, the proposed agenda items (including election of directors, approval of financial statements, remuneration, and authorization for share issues/warrants), and specific proposals related to these items. This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2022-04-04 English
Kallelse till årsstämma i Medivir AB (publ)
AGM Information Classification · 100% confidence The document is titled "Kallelse till årsstämma i Medivir AB (publ)" which translates to "Notice of Annual General Meeting in Medivir AB (publ)". The text details the date, time, location, procedures for participation (in person or by advance voting), agenda items (including election of board members, auditor, remuneration, and proposals for new share issues/warrants), and specific proposals to be voted upon. This content perfectly matches the definition of materials related to an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2022-04-04 Swedish
Audit Report / Information 2021
Audit Report / Information Classification · 95% confidence The document is titled "MEDIVIR AB – BOKSLUTSKOMMUNIKÉ JANUARI – DECEMBER 2021" (Medivir AB - Year-End Report Communication January - December 2021). It contains detailed financial summaries for the fourth quarter (Oktober - December) and the full year (Januari - December 2021), including revenue, EBITDA, cash flow, and year-end cash positions. It also discusses significant clinical and business development events throughout the year and provides a CEO's review. This structure—a comprehensive review of the full fiscal year's financial performance and operational highlights—is characteristic of an Annual Report or a document closely associated with it, such as a year-end earnings release that incorporates the full annual review. Given the depth of financial data covering the entire year and the title indicating a 'Year-End Communication' (Bokslutskommuniké), it functions as the primary annual financial disclosure. While it is not explicitly labeled '10-K' (the SEC filing equivalent), in a general corporate filing context, a comprehensive year-end financial report is best classified as an Annual Report (AR is usually for standalone audit reports, while 10-K covers the full annual performance). Since the document provides the full annual financial summary and operational review, it aligns best with the 'Annual Report' category, even if it's a local market equivalent or a preliminary version preceding the final 10-K filing, or if 'AR' is interpreted broadly. However, looking at the definitions, '10-K' is specifically for the 'Official yearly report covering company activity and full financial performance.' This document serves that exact purpose for the Swedish company Medivir. The length (over 42k characters) confirms it is a substantial report, not just a brief announcement (ruling out RPA/RNS). FY 2021
2022-02-15 Swedish
Audit Report / Information 2021
Audit Report / Information Classification · 98% confidence The document is explicitly titled "MEDIVIR AB – YEAR-END REPORT" and covers financial summaries for "JANUARY – DECEMBER 2021" (a full fiscal year). It contains detailed financial figures (Net turnover, EBITDA, EPS, Cash flow) for both the quarter and the full year, alongside extensive operational updates and a CEO's message reviewing the year. This structure is characteristic of a comprehensive annual financial report, which aligns with the definition of an Annual Report (10-K), although this specific document appears to be a Swedish equivalent or a detailed annual report released outside the standard SEC 10-K filing structure. Given the comprehensive nature covering the entire fiscal year's performance, '10-K' is the most appropriate classification among the provided options for a full-year financial report. FY 2021
2022-02-15 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document details a change in shareholding, specifically a 'Sell' transaction by Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension. It explicitly states the 'Reason for major shareholding notification' and provides the resulting share quantity (5,541,880 shares) and percentage (9.94315%). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the code MRQ.
2022-02-07 English
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 98% confidence The document details a change in shareholding percentage by a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension), showing the 'Before' and 'After' transaction details, including the exact number of shares (5,612,725) and the resulting percentage (10.07026%). This structure is characteristic of mandatory notifications regarding significant changes in ownership thresholds. This aligns perfectly with the definition of Major Shareholding Notification (MRQ). It is not an earnings release (ER), a full annual report (10-K), or a director's dealing (DIRS), but specifically tracks major ownership changes.
2021-12-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.